Advertisement

Topics

Novo Nordisk Will Eat Itself In Obesity

07:27 EDT 29 Jun 2017 | SCRIP

The Danish diabetes specialist is forging ahead with pivotal trials for its latest GLP-1 offering semaglutide in obesity after highly...

      

Related Stories

 

Original Article: Novo Nordisk Will Eat Itself In Obesity

NEXT ARTICLE

More From BioPortfolio on "Novo Nordisk Will Eat Itself In Obesity"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Obesity
Obesity is the condition in which excess fat has accumulated in the body (mostly in subcutaneous tissues). clinical obesity is considered to be present when a person has a BMI of over 30 (Oxford Dictionary of Medicine). It is becoming increasing common i...